Article citation: muhammad hasib khalil, mbbs *,mobeen haider, mbbs,sanjay mehta, md.Dec.26, 2023, late thrombosis of gore cardioform septal occluder device in a patient with history of patent foramen ovale closure.Elsevier, (2024) 1386-1390.The gore® cardioform septal occluder instructions for use states: adverse events associated with the use of the occluder may include but are not limited to: thrombosis or thromboembolic event.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
This case highlights the unique complication of device thrombosis in a patient with a gore® cardioform septal occluder device 3 years after pfo closure.Imaging at 1 and 2 years, showed no thrombus.Approximately 3 years after device closure, a transesophageal echocardiogram (tee) was performed which showed a 3.1 x 3.4 cm mobile mass attached to the pfo closure device in the left atrium.This mass was thought to be a thrombus due to its location and attachment to the pfo closure device.The patient was started on intravenous (iv) heparin and eventually transitioned to oral warfarin were given for two months.A repeat tee showed complete resolution of the thrombus.
|